Health Secretary Herbosa Resigns Voluntarily, Palace Says
Politics
2026年7月14日
5
Inquirer NewsInfo

Health Secretary Herbosa Resigns Voluntarily, Palace Says

AI サマリー

Cabinet Secretary Benjamin Abalos denied claims that Health Secretary Teodoro Herbosa was forced to resign, stating it was voluntary due to health reasons. President Marcos Jr. has appointed orthopedic surgeon Dr. Jose Brittanio Pujalte Jr. as the new DOH chief.

Cabinet Secretary Benjamin “Benhur” Abalos has denied claims that outgoing Health Secretary Teodoro Herbosa was forced to step down from his post by President Ferdinand Marcos Jr. Abalos told reporters in Malacañang on Monday that Herbosa filed his courtesy resignation “voluntarily,” and the President accepted it so he could recuperate well. President Marcos named veteran orthopedic surgeon Dr. Jose Brittanio “Brix” Pujalte Jr. as the new chief of the Department of Health (DOH), replacing Herbosa who had served for three years. READ: Jose Pujalte is Marcos’ new DOH secretary In his message to DOH officials, a copy of which was obtained by the Inquirer, Herbosa said he tendered his courtesy resignation “to take care of myself.” Herbosa, who had been on sick leave since July 6, said he would need three to four months of “extensive rehabilitation” following his recent replacement surgery on both his knees. “I find it unfair that I will not be able to devote my full time and effort to important matters of DOH,” he added. In a message, Herbosa thanked Marcos for the “complete trust and confidence he placed in my service at the DOH.” It was under Herbosa’s term that the DOH implemented reforms, including the zero-balance billing in government hospitals. He also initiated the establishment of Bagong Urgent Care and Ambulatory Service (Bucas) centers aimed at decongesting the overcrowded emergency rooms of public hospitals. It was also under Herbosa, as chair of the Philippine Health Insurance Corp. (PhilHealth), that the state health insurance implemented a 30-percent in 2024 and then a 50-percent increase in 2025 in almost all of the 9,000 medical and procedural case rates it offers. AHW, who has been calling for Herbosa to step down as DOH chief for years, said his resignation “should have come much earlier, as his tenure has failed to bring meaningful improvements to the conditions of health workers and the country’s public healthcare system.” The group maintained that his resignation should not absolve him from answering complaints and allegations pending before the Office of the Ombudsman. “These concerns are not merely matters of numbers, documents, or government procedures; they have direct consequences on the lives of Filipino patients,” the AHW said. “While millions of Filipinos continue to struggle to afford medicines, hospital care, and essential health services, every peso lost, wasted, or mismanaged from the public healthcare system represents an opportunity taken away from patients who urgently need assistance,” it added. READ: Herbosa says recovery prompted exit, cites DOH gains Herbosa had been the subject of reported Cabinet reshuffles due to past controversies, but the Palace had always denied he was being booted out. There were also numerous calls for Herbosa to step down as DOH chief since he assumed the post in June 2023. He had also been the subject of reported Cabinet reshuffles due to past controversies, but the Palace had always denied he was being booted out. His name was dragged into the delay in the payment of health emergency allowance of those who served during the COVID-19 pandemic. Herbosa was also accused of being complicit in the transfer of P60 billion of excess funds of the Philippine Health Insurance Corp. (PhilHealth), where he serves as its chair, to the national treasury. He was also called to step down by health advocates several times for his posing with executives of a tobacco company. Herbosa is currently facing multiple complaints before the Office of the Ombudsman over alleged irregularities involving billions of pesos in public funds. /cb

多角的分析

経済的影響

保健大臣の辞任は、医療セクターへの投資や政策の継続性に一時的な不確実性をもたらす可能性がある。しかし、新任のプルハルテ大臣が医療従事者の待遇改善や公衆衛生システムの強化といったエルボサ前大臣の政策を引き継ぐかどうかが、長期的な経済的影響を左右する。特に、PhilHealthのケースレート引き上げ計画は、医療費負担能力に影響を与えるため、その進捗が注視される。

投資家心理

保健大臣の交代は、医療関連企業への投資判断において、政策の安定性という観点から注目される。エルボサ前大臣はPhilHealthのケースレート引き上げを推進したが、その実現可能性や財源確保策が投資家の関心事となる。新任大臣が同様の政策を継続するか、あるいは新たな医療政策を打ち出すかによって、医薬品メーカーや病院運営会社などの株価に影響を与える可能性がある。

社会的影響

エルボサ前大臣の辞任は、医療従事者団体(AHW)が指摘するように、医療従事者の待遇改善や公衆衛生システムの効率化という、フィリピン国民が直面する喫緊の課題への対応が不十分であったという社会的な懸念を浮き彫りにした。監察官室に係争中の訴訟が複数あることから、公的資金の透明性や管理体制に対する国民の不信感が募る可能性がある。新任大臣がこれらの課題にどう取り組み、国民の信頼を回復できるかが問われる。

市民の声

市民の立場からは、医療費の高騰や医療サービスへのアクセスが依然として大きな懸念事項である。エルボサ前大臣の在任中に進められたPhilHealthのケースレート引き上げは、医療費の自己負担額に直接影響するため、多くの国民がその動向を注視している。また、公的資金の不正疑惑は、医療システム全体への不信感に繋がり、必要な医療を受けられない人々への影響が懸念される。新保健大臣には、国民が安心して医療を受けられる体制の構築が期待される。

背景・歴史的文脈

フィリピンでは、公衆衛生システムの脆弱性が長年の課題となっている。特に、COVID-19パンデミックを経て、医療従事者の待遇改善や医療インフラの整備が喫緊の課題として認識されている。保健大臣の交代は、しばしば政治的な思惑や過去の論争と結びつけられる傾向があり、政策の継続性や公的資金の透明性に対する国民の懸念は根強い。エルボサ氏の辞任も、こうした背景の中で、単なる健康上の理由だけでなく、複雑な政治力学や行政上の問題が絡み合っている可能性が指摘されている。

原文ソース

Inquirer NewsInfo

原文を読む